These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15232326)

  • 1. A double-blind, randomized study of olanzapine and olanzapine/fluoxetine combination for major depression with psychotic features.
    Rothschild AJ; Williamson DJ; Tohen MF; Schatzberg A; Andersen SW; Van Campen LE; Sanger TM; Tollefson GD
    J Clin Psychopharmacol; 2004 Aug; 24(4):365-73. PubMed ID: 15232326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
    J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An integrated analysis of olanzapine/fluoxetine combination in clinical trials of treatment-resistant depression.
    Trivedi MH; Thase ME; Osuntokun O; Henley DB; Case M; Watson SB; Campbell GM; Corya SA
    J Clin Psychiatry; 2009 Mar; 70(3):387-96. PubMed ID: 19284928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, fluoxetine, and venlafaxine in treatment-resistant depression.
    Corya SA; Williamson D; Sanger TM; Briggs SD; Case M; Tollefson G
    Depress Anxiety; 2006; 23(6):364-72. PubMed ID: 16710853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An open study of olanzapine and fluoxetine for psychotic major depressive disorder: interim analyses.
    Matthews JD; Bottonari KA; Polania LM; Mischoulon D; Dording CM; Irvin R; Fava M
    J Clin Psychiatry; 2002 Dec; 63(12):1164-70. PubMed ID: 12523877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoxetine and olanzapine combination therapy in treatment-resistant major depression: review of efficacy and safety data.
    Bobo WV; Shelton RC
    Expert Opin Pharmacother; 2009 Sep; 10(13):2145-59. PubMed ID: 19640209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of olanzapine/fluoxetine combination vs fluoxetine monotherapy following successful combination therapy of treatment-resistant major depressive disorder.
    Brunner E; Tohen M; Osuntokun O; Landry J; Thase ME
    Neuropsychopharmacology; 2014 Oct; 39(11):2549-59. PubMed ID: 24801768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olanzapine/Fluoxetine combination in children and adolescents with bipolar I depression: a randomized, double-blind, placebo-controlled trial.
    Detke HC; DelBello MP; Landry J; Usher RW
    J Am Acad Child Adolesc Psychiatry; 2015 Mar; 54(3):217-24. PubMed ID: 25721187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of olanzapine alone and olanzapine/fluoxetine combination on health-related quality of life in patients with bipolar depression: secondary analyses of a double-blind, placebo-controlled, randomized clinical trial.
    Shi L; Namjoshi MA; Swindle R; Yu X; Risser R; Baker RW; Tohen M
    Clin Ther; 2004 Jan; 26(1):125-34. PubMed ID: 14996525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and safety of the combination of fluoxetine and olanzapine in outpatients with bipolar depression: an open-label, randomized, flexible-dose study in Puerto Rico.
    Tamayo JM; Sutton VK; Mattei MA; Diaz B; Jamal HH; Vieta E; Zarate CA; Fumero I; Tohen M
    J Clin Psychopharmacol; 2009 Aug; 29(4):358-61. PubMed ID: 19593175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of comorbid anxiety on treatment response in bipolar depression.
    Tohen M; Calabrese J; Vieta E; Bowden C; Gonzalez-Pinto A; Lin D; Xu W; Corya S
    J Affect Disord; 2007 Dec; 104(1-3):137-46. PubMed ID: 17512607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olanzapine/fluoxetine combination for treatment-resistant depression: a controlled study of SSRI and nortriptyline resistance.
    Shelton RC; Williamson DJ; Corya SA; Sanger TM; Van Campen LE; Case M; Briggs SD; Tollefson GD
    J Clin Psychiatry; 2005 Oct; 66(10):1289-97. PubMed ID: 16259543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study.
    Sanger TM; Grundy SL; Gibson PJ; Namjoshi MA; Greaney MG; Tohen MF
    J Clin Psychiatry; 2001 Apr; 62(4):273-81. PubMed ID: 11379842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.
    Tohen M; Vieta E; Calabrese J; Ketter TA; Sachs G; Bowden C; Mitchell PB; Centorrino F; Risser R; Baker RW; Evans AR; Beymer K; Dube S; Tollefson GD; Breier A
    Arch Gen Psychiatry; 2003 Nov; 60(11):1079-88. PubMed ID: 14609883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A preliminary, randomized trial of fluoxetine, olanzapine, and the olanzapine-fluoxetine combination in women with borderline personality disorder.
    Zanarini MC; Frankenburg FR; Parachini EA
    J Clin Psychiatry; 2004 Jul; 65(7):903-7. PubMed ID: 15291677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, and fluoxetine in treatment-resistant major depressive disorder.
    Thase ME; Corya SA; Osuntokun O; Case M; Henley DB; Sanger TM; Watson SB; Dubé S
    J Clin Psychiatry; 2007 Feb; 68(2):224-36. PubMed ID: 17335320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring treatment response in psychotic depression: the Psychotic Depression Assessment Scale (PDAS) takes both depressive and psychotic symptoms into account.
    Østergaard SD; Meyers BS; Flint AJ; Mulsant BH; Whyte EM; Ulbricht CM; Bech P; Rothschild AJ;
    J Affect Disord; 2014 May; 160():68-73. PubMed ID: 24439830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic association study of treatment response with olanzapine/fluoxetine combination or lamotrigine in bipolar I depression.
    Perlis RH; Adams DH; Fijal B; Sutton VK; Farmen M; Breier A; Houston JP
    J Clin Psychiatry; 2010 May; 71(5):599-605. PubMed ID: 20021991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical relevance of depressive symptom improvement in bipolar I depressed patients.
    Williamson D; Brown E; Perlis RH; Ahl J; Baker RW; Tohen M
    J Affect Disord; 2006 Jun; 92(2-3):261-6. PubMed ID: 16563521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Association of Baseline Suicidality With Treatment Outcome in Psychotic Depression.
    Bingham KS; Rothschild AJ; Mulsant BH; Whyte EM; Meyers BS; Banerjee S; Szanto K; Flint AJ;
    J Clin Psychiatry; 2017; 78(8):1149-1154. PubMed ID: 28445632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.